PlainRecalls
FDA Drug Moderate Class II Terminated

Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01

Reported: September 4, 2024 Initiated: August 21, 2024 #D-0648-2024

Product Description

Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01

Reason for Recall

Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.

Details

Units Affected
4554 bottles
Distribution
USA nationwide.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 4554 bottles.
Why was this product recalled?
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 4, 2024. Severity: Moderate. Recall number: D-0648-2024.